Hyperkalemia as a limiting factor of neurohormonal blockade/modulation in everyday clinical practice
Introduction and objectives: Neurohormonal blockade (NB)/modulation is the combination of two renin-angiotensin-aldosterone system inhibitors (RAASi) with a beta blocker. It is the core therapy for heart failure with reduced ejection fraction (HFrEF). While improving long term prognosis, it also ind...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-07-01
|
Series: | Revista Portuguesa de Cardiologia |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0870255122000324 |